KIMBERLY HEBERT: Open Payments
NPI 1467436816 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$707 in 35 payments from 15 companies in 2025. Trend: 2023 $471 · 2024 $568 · 2025 $707
Food & beverage: $707
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $215 |
| Novo Nordisk Inc | 5 | $88 |
| PFIZER INC. | 5 | $74 |
| Abbott Laboratories | 3 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $45 |
| Lilly USA, LLC | 2 | $36 |
| Astellas Pharma US Inc | 2 | $33 |
| Medtronic, Inc. | 1 | $30 |
| Seqirus USA Inc | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
Products named: FARXIGA, AIRSUPRA, FREESTYLE LIBRE 3, NURTEC ODT, BREZTRI, Kerendia, MOUNJARO, Veozah.
Industry payments across KS — which companies pay providers there.
